Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Viral Vaccine market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Viral Vaccine market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Viral Vaccine market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Viral Vaccine products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Viral Vaccine products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Viral Vaccine market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Viral Vaccine development has been the leading industry trend of Viral Vaccine market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Viral Vaccine Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Attenuated Vaccine,Inactivated Vaccine, Other |
| By Application Outlook |
Adults,Children, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
GSK,Merck,Novartis,Pfizer,Sanofi Pasteur,Bayer,Zoetis,AstraZeneca,Johnson & Johnson,CSL Limited,Astellas Pharma,Emergent BioSolutions,MedImmune,Serum Institute of India,Encephalitis ,Cochrane Collaboration,Sonic HealthPlus,Superdrug Health,CNBG,Changsheng Life,Baxter,ChengDa Bio,Boehringer Ingelheim,SINOVAC BIOTECH,Hissen,Walvax Biotechnology,Rong An,NuoCheng Bio,Hualan Bio,Tiantan Biological |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- GSK
- Merck
- Novartis
- Pfizer
- Sanofi Pasteur
- Bayer
- Zoetis
- AstraZeneca
- Johnson & Johnson
- CSL Limited
- Astellas Pharma
- Emergent BioSolutions
- MedImmune
- Serum Institute of India
- Encephalitis
- Cochrane Collaboration
- Sonic HealthPlus
- Superdrug Health
- CNBG
- Changsheng Life
- Baxter
- ChengDa Bio
- Boehringer Ingelheim
- SINOVAC BIOTECH
- Hissen
- Walvax Biotechnology
- Rong An
- NuoCheng Bio
- Hualan Bio
- Tiantan Biological
Viral Vaccine Market, By Type
- Attenuated Vaccine
- Inactivated Vaccine
- Other
Viral Vaccine Market, By Application
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
Chapter 1 Viral Vaccine Market Overview
1.1 Viral Vaccine Definition
1.2 Global Viral Vaccine Market Size Status and Outlook (2014-2027)
1.3 Global Viral Vaccine Market Size Comparison by Region (2014-2027)
1.4 Global Viral Vaccine Market Size Comparison by Type (2014-2027)
1.5 Global Viral Vaccine Market Size Comparison by Application (2014-2027)
1.6 Global Viral Vaccine Market Size Comparison by Sales Channel (2014-2027)
1.7 Viral Vaccine Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts on Current Market
1.7.5 Post-Strategies of COVID-19 Outbreak
Chapter 2 Viral Vaccine Market Segment Analysis by Player
2.1 Global Viral Vaccine Sales and Market Share by Player (2017-2019)
2.2 Global Viral Vaccine Revenue and Market Share by Player (2017-2019)
2.3 Global Viral Vaccine Average Price by Player (2017-2019)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Viral Vaccine Market Segment Analysis by Type
3.1 Global Viral Vaccine Market by Type
3.1.1 Attenuated Vaccine
3.1.2 Inactivated Vaccine
3.2 Global Viral Vaccine Sales and Market Share by Type (2014-2019)
3.3 Global Viral Vaccine Revenue and Market Share by Type (2014-2019)
3.4 Global Viral Vaccine Average Price by Type (2014-2019)
3.5 Leading Players of Viral Vaccine by Type in 2019
3.6 Conclusion of Segment by Type
Chapter 4 Viral Vaccine Market Segment Analysis by Application
4.1 Global Viral Vaccine Market by Application
4.1.1 Adults
4.1.2 Children
4.2 Global Viral Vaccine Sales and Market Share by Application (2014-2019)
4.3 Leading Consumers of Viral Vaccine by Application in 2019
4.4 Conclusion of Segment by Application
Chapter 5 Viral Vaccine Market Segment Analysis by Sales Channel
5.1 Global Viral Vaccine Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Viral Vaccine Sales and Market Share by Sales Channel (2014-2019)
5.3 Leading Distributors/Dealers of Viral Vaccine by Sales Channel in 2019
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Viral Vaccine Market Segment Analysis by Region
6.1 Global Viral Vaccine Market Size and CAGR by Region (2014-2027)
6.2 Global Viral Vaccine Sales and Market Share by Region (2014-2019)
6.3 Global Viral Vaccine Revenue and Market Share by Region (2014-2019)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Viral Vaccine Market Share by Type
6.4.3 North America Viral Vaccine Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Viral Vaccine Market Share by Type
6.5.3 Europe Viral Vaccine Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Viral Vaccine Market Share by Type
6.6.3 Asia-Pacific Viral Vaccine Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Viral Vaccine Market Share by Type
6.7.3 South America Viral Vaccine Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Viral Vaccine Market Share by Type
6.8.3 Middle East & Africa Viral Vaccine Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Viral Vaccine Players
7.1 GSK
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.1.4 COVID-19 Impact on GSK
7.2 Merck
7.3 Novartis
7.4 Pfizer
7.5 Sanofi Pasteur
7.6 Bayer
7.7 Zoetis
7.8 AstraZeneca
7.9 Johnson & Johnson
7.10 CSL Limited
7.11 Astellas Pharma
7.12 Emergent BioSolutions
7.13 MedImmune
7.14 Serum Institute of India
7.15 Encephalitis
7.16 Cochrane Collaboration
7.17 Sonic HealthPlus
7.18 Superdrug Health
7.19 CNBG
7.20 Changsheng Life
7.21 Baxter
7.22 ChengDa Bio
7.23 Boehringer Ingelheim
7.24 SINOVAC BIOTECH
7.25 Hissen
7.26 Walvax Biotechnology
7.27 Rong An
7.28 NuoCheng Bio
7.29 Hualan Bio
7.29 Hualan Bio
Chapter 8 Upstream and Downstream Analysis of Viral Vaccine
8.1 Industrial Chain of Viral Vaccine
8.2 Upstream of Viral Vaccine
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.2.4 Manufacturing Cost Structure
8.2.5 Manufacturing Process
8.3 Downstream of Viral Vaccine
8.3.1 Leading Distributors/Dealers of Viral Vaccine
8.3.2 Leading Consumers of Viral Vaccine
Chapter 9 Development Trend of Viral Vaccine (2020-2027)
9.1 Global Viral Vaccine Market Size (Sales and Revenue) Forecast (2020-2027)
9.2 Global Viral Vaccine Market Size and CAGR Forecast by Region (2020-2027)
9.3 Global Viral Vaccine Market Size and CAGR Forecast by Type (2020-2027)
9.4 Global Viral Vaccine Market Size and CAGR Forecast by Application (2020-2027)
9.5 Global Viral Vaccine Market Size and CAGR Forecast by Sales Channel (2020-2027)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
